Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma, Journal of Enzyme Inhibition and Medicinal Chemistry, January 2019, Taylor & Francis,
DOI: 10.1080/14756366.2019.1613987.
You can read the full text:

Read

Contributors

The following have contributed to this page